VM7luc4E2 人乳腺癌雌激素受体报告基因细胞系 / BioVector® VM7luc4E2 Human Breast Cancer ER Reporter Cell Line
- 价 格:¥598950
- 货 号:BioVector® VM7luc4E2
- 产 地:北京
- BioVector NTCC典型培养物保藏中心
- 联系人:Dr.Xu, Biovector NTCC Inc.
电话:400-800-2947 工作微信:1843439339 (QQ同号)
邮件:Biovector@163.com
手机:18901268599
地址:北京
- 已注册
BioVector® VM7luc4E2 人乳腺癌雌激素受体报告基因细胞系 / BioVector® VM7luc4E2 Human Breast Cancer ER Reporter Cell Line
通用定义 / General Definition:
BioVector® VM7luc4E2(又名 VM7 或经过改进的 BG1Luc4E2)是一种高度敏感的人源报告基因细胞系,专门用于检测内分泌干扰物 (EDCs) 和雌激素活性。该细胞系由人乳腺腺癌细胞衍生而来,稳定转染了由雌激素应答元件 (ERE) 驱动的萤火虫荧光素酶 (Firefly Luciferase) 报告基因质粒。由于其内源性表达高水平的人雌激素受体($\alpha$ 和 $\beta$),VM7luc4E2 被美国环保署 (EPA) 和 OECD 认可为评估化学品雌激素受体激动或拮抗活性的标准体外实验模型。
BioVector® VM7luc4E2 (also known as VM7 or optimized BG1Luc4E2) is a highly sensitive human-derived reporter cell line specifically designed for the detection of Endocrine Disrupting Chemicals (EDCs) and estrogenic activity. Derived from a human breast adenocarcinoma lineage, these cells are stably transfected with a Firefly Luciferase reporter gene plasmid driven by Estrogen Response Elements (ERE). Expressing high levels of endogenous human estrogen receptors ($\alpha$ and $\beta$), VM7luc4E2 is recognized by the US EPA and OECD as a gold-standard in vitro model for assessing the estrogen receptor agonistic or antagonistic activities of chemicals.
BioVector® VM7luc4E2 技术说明书 (Technical Datasheet)
中文版说明书 (Chinese Datasheet)
1. 产品基本信息
产品名称: BioVector® VM7luc4E2 雌激素报告基因细胞系
母本细胞: VM7 (原名 BG-1, 人乳腺癌细胞)
生长特性: 贴壁生长
报告基因: ERE-驱动的萤火虫荧光素酶 (Firefly Luciferase)
细胞形态: 上皮样,呈多角形
2. 培养条件
维持培养基: BioVector® DMEM/F12 (无酚红) 培养基
血清添加: 10% BioVector® 优质胎牛血清 (FBS)
筛选抗生素: 含有适量的 G418 以维持报告基因的稳定性。
实验前处理: 为降低背景活性,实验前通常需在含有 5% 活性炭脱色血清 (DCC-FBS) 的无酚红培养基中饥饿处理 24-48 小时。
培养环境: 37 摄氏度,5% CO2
3. 细胞应用
内分泌干扰筛选: 定量检测农药、化妆品成分或工业化学品的类雌激素活性。
药物开发: 评估新型选择性雌激素受体调节剂 (SERMs) 的效能。
环境监测: 监测水质或土壤提取物中的生物有效性雌激素浓度。
4. 注意事项
酚红敏感性: 酚红具有微弱的雌激素活性,所有功能性实验必须使用无酚红培养基。
血清选择: 必须使用经过活性炭处理的血清 (DCC-FBS) 以去除内源性类固醇激素,否则会导致背景信号过高。
English Datasheet
1. General Product Information
Product Name: BioVector® VM7luc4E2 Human Breast Cancer ER Reporter Cell Line
Parental Line: VM7 (formerly BG-1, Human Breast Adenocarcinoma)
Growth Properties: Adherent
Reporter Gene: ERE-driven Firefly Luciferase
Morphology: Epithelial-like, polygonal.
2. Culture Conditions
Maintenance Medium: BioVector® DMEM/F12 (Phenol Red-Free) Medium
Serum Supplement: 10% BioVector® Fetal Bovine Serum (FBS)
Selection Marker: Maintain with G418 to ensure the stability of the luciferase expression cassette.
Assay Preparation: To minimize background signaling, cells are typically starved in medium containing 5% Dextran-Coated Charcoal-stripped FBS (DCC-FBS) for 24-48 hours prior to chemical exposure.
Incubation: 37 degrees Celsius, 5% CO2.
3. Applications
Endocrine Disruptor Screening: Quantifying the estrogenic potential of pesticides, cosmetic ingredients, or industrial chemicals (e.g., BPA).
Pharmaceutical Research: Evaluating the potency of novel Selective Estrogen Receptor Modulators (SERMs).
Environmental Monitoring: Detecting bioavailable estrogenic activity in water samples or environmental leachates.
4. Key Usage Notes
Phenol Red Interference: Phenol red acts as a weak estrogen mimic; therefore, Phenol Red-Free media must be used for all transactivation assays.
Hormone Depletion: The use of DCC-FBS is critical during the assay phase to remove endogenous hormones that would otherwise cause high baseline luciferase activity.
注意 / Note: BioVector® VM7luc4E2 具有极高的灵敏度,操作过程中应严格防止实验室塑料制品的潜在浸出物(如邻苯二甲酸酯)干扰实验。
BioVector® VM7luc4E2 is extremely sensitive; precautions should be taken to prevent interference from potential leachable endocrine disruptors (e.g., phthalates) found in laboratory plasticware.
BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心
E-mail: BioVector@163.com
http://www.biovector.net
- 公告/新闻




